Ductal Carcinoma In Situ Tied to Threefold Higher Risk for Death
FRIDAY, Oct. 2, 2020 -- There is a threefold higher risk for dying of breast cancer after a diagnosis of ductal carcinoma in situ (DCIS), according to a study published online Sept. 16 in JAMA Network Open.
Vasily Giannakeas, M.P.H., from...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Pharmaceuticals | Study